13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
117 檔
28.2%
The Q1 2024 SEC filing reveals that Privium Fund Management B.V. held a total portfolio value of $544.2M, covering 117 public equity positions.
During Q1 2024, Privium Fund Management B.V.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 11.98% | -2.12% | -20.19% | |
| 2 | SHOP | Shopify Inc - Class A | Stock-Tech | 8.55% | -2.29% | — | |
| 3 | TSLA | Tesla Inc | Stock-Consumer Disc | 7.93% | +0.44% | +42.86% | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 6.79% | +0.71% | — | |
| 5 | OXY-WS | Occidental Petroleum-cw27 | Stock-Other | 5.71% | — | — | |
| 6 | SNOW | Snowflake Inc | Stock-Tech | 5.57% | — | — | |
| 7 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 3.27% | +0.05% | — | |
| 8 | SE | Sea Ltd-adr | Stock-Comm Services | 3.01% | -2.38% | EXIT | |
| 9 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 2.73% | -1.80% | +4.71% | |
| 10 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.68% | +0.49% | +29.19% | |
| 11 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 2.63% | +0.13% | +4.37% | |
| 12 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 2.42% | — | -14.29% | |
| 13 | DDOG | Datadog Inc - Class A | Stock-Tech | 2.18% | — | — | |
| 14 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 2.09% | -1.28% | — | |
| 15 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 2.01% | — | +15.85% | |
| 16 | NET | Cloudflare Inc - Class A | Stock-Tech | 1.94% | — | — | |
| 17 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.75% | -0.27% | +13.88% | |
| 18 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 1.69% | -0.03% | +0.86% | |
| 19 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.60% | — | -48.29% | |
| 20 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.60% | — | +104.39% | |
| 21 | NVDA | Nvidia CORP | Stock-Tech | 1.45% | +0.04% | -16.67% | |
| 22 | ✓ | Fusion Pharmaceuticals Inc | Stock-Other | 1.43% | — | +77.18% | |
| 23 | CRWD | Crowdstrike Holdings Inc - A | Stock-Tech | 1.28% | — | -6.25% | |
| 24 | MSFT | Microsoft CORP | Stock-Tech | 1.17% | — | -35.00% | |
| 25 | MRNA | Moderna Inc | Stock-Healthcare | 1.13% | +0.07% | -9.12% | |
| 26 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 1.03% | -0.09% | — | |
| 27 | CPNG | Coupang Inc | Stock-Consumer Disc | 0.94% | — | — | |
| 28 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.88% | — | — | |
| 29 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 0.83% | -0.21% | -3.69% | |
| 30 | QURE | uniQure N.V. | Stock-Other | 0.80% | +1.12% | +30.34% | |
| 31 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.73% | — | — | |
| 32 | HEI-A | Heico Corp-class A | Stock-Other | 0.49% | — | — | |
| 33 | UAA | Under Armour Inc-class A | Stock-Consumer Disc | 0.44% | — | +0.77% | |
| 34 | BIIB | Biogen Inc | Stock-Healthcare | 0.41% | +0.25% | +85.49% | |
| 35 | LBTYA | Liberty Global Ltd. | Stock-Other | 0.39% | — | — | |
| 36 | CLBT | Cellebrite DI Ltd. | Stock-Other | 0.37% | — | +846.31% | |
| 37 | ✓ | Stock-Other | 0.37% | — | +17.24% | ||
| 38 | AMD | Advanced Micro Devices | Stock-Tech | 0.36% | +3.99% | — | |
| 39 | BF-B | Brown-forman Corp-class B | Stock-Other | 0.36% | — | — | |
| 40 | ✓ | Mirion Technologies Inc | Stock-Other | 0.32% | — | +8.38% | |
| 41 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.30% | -0.12% | +28.43% | |
| 42 | BYND 0 03-15-27Bond | Beyond Meat Inc | Bond | 0.29% | — | — | |
| 43 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.26% | -0.11% | -7.96% | |
| 44 | C | Citigroup Inc | Stock-Financials | 0.25% | — | -1.18% | |
| 45 | ✓ | Intuitive Machines Inc | Stock-Other | 0.24% | — | — | |
| 46 | ✓ | Landsea Homes CORP | Stock-Other | 0.24% | — | +80.48% | |
| 47 | FOX | Fox CORP - Class B | Stock-Comm Services | 0.24% | — | — | |
| 48 | NOV | Nov Inc | Stock-Energy | 0.23% | -0.02% | +24.57% | |
| 49 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.23% | +0.03% | — | |
| 50 | PFE | Pfizer Inc | Stock-Healthcare | 0.22% | -0.31% | EXIT |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 117 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPOT, SHOP, TSLA) accounted for 28.2% of total reported equity market value during Q1 2024.
During Q1 2024, Privium Fund Management B.V.'s top holdings by market value included SPOT (12.0%)、SHOP (8.6%)、TSLA (7.9%). The largest single position, SPOT, represented 12.0% of total portfolio value.
In Q1 2024, Privium Fund Management B.V. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.